TP53 and endometrial cancer: The KEGG signalling pathway analysis showed that the target genes played pivotal roles in the following pathways: ‘p53 signalling pathway’, ‘Transcriptional misregulation in cancer’, ‘EGFR tyrosine kinase inhibitor resistance’, and ‘Endometrial cancer’.